Skip to content

Clinical trials

Immunoglobulin Light-chain Amyloidosis trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Country / region: Greece Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20161
20171
20191
20203
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Prothena Biosciences Ltd.3
Alexion Pharmaceuticals, Inc.2
European Myeloma Network B.V.2
European Organisation for Research and Treatment of Cancer - EORTC1
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.1
Oncopeptides AB1
Stichting European Myeloma Network1
University of Athens1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis12
Amyloidosis3
Paraproteinemias3
Recurrence2
Alzheimer Disease1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1
Carcinoma, Ovarian Epithelial1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.